Taldefgrobep Alfa and the Phase 3 RESILIENT Trial in Spinal Muscular Atrophy.
Servais L, Lair LL, Connolly AM, Byrne BJ, Chen KS, Coric V, Qureshi I, Durham S, Campbell DJ, Maclaine G, Marin J, Bechtold C.
Servais L, et al. Among authors: durham s.
Int J Mol Sci. 2024 Sep 24;25(19):10273. doi: 10.3390/ijms251910273.
Int J Mol Sci. 2024.
PMID: 39408601
Free PMC article.
Review.